ARMP
ARMP
AMEX · Biotechnology

Armata Pharmaceuticals Inc

$3.87
+0.15 (+4.03%)
Financial Highlights (FY 2026)
Revenue
4.99M
Net Income
-176,894,495
Gross Margin
—
Profit Margin
-3,544.0%
Rev Growth
-3.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 64.0% 64.0%
Operating Margin -747.0% -672.3% -25.7% -26.9%
Profit Margin -3,544.0% -3,366.8% -31.4% -24.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 4.99M 5.19M 51.72M 48.38M
Gross Profit — — 33.09M 30.96M
Operating Income -37,279,853 -34,880,827 -13,268,820 -13,017,580
Net Income -176,894,495 -165,511,015 -16,237,176 -12,069,043
Gross Margin — — 64.0% 64.0%
Operating Margin -747.0% -672.3% -25.7% -26.9%
Profit Margin -3,544.0% -3,366.8% -31.4% -24.9%
Rev Growth -3.8% -3.8% -2.8% -3.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 107.00M 137.33M
Total Equity — — 94.95M 97.16M
D/E Ratio — — 1.13 1.41
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -35,726,351 -35,284,367 -19,844,642 -21,697,061
Free Cash Flow — — -12,228,215 -11,985,347